DRREDDY's weekly performance was disappointing, with a return of -1.35%, indicating a decline in stock value. The stock's volatility was relatively high at 24.4%, suggesting significant price fluctuations. Compared to its peers, DRREDDY outperformed DIVISLAB but underperformed SUNPHARMA. The stock's risk profile was moderate, with a Sharpe Ratio of -0.29 and a Max Drawdown of -2.23%.

[Volatility: 24.4%]